Low-Density Lipoprotein Cholesterol Control as a Performance Measure A National Analysis of the VHA

被引：1
|
作者：
Jain, Sneha S. [1 ,2 ]
Skye, Megan [3 ]
Din, Natasha [3 ]
Furst, Adam [1 ,2 ,3 ]
Maron, David J. [1 ,2 ,4 ]
Heidenreich, Paul [3 ]
Kalwani, Neil [1 ,2 ,3 ]
Bhatt, Ankeet S. [1 ,2 ,5 ,6 ]
Sandhu, Alexander T. [1 ,2 ,3 ,4 ]
Rodriguez, Fatima [1 ,2 ]
机构：
[1] Stanford Univ, Div Cardiovasc Med, Stanford, CA USA
[2] Stanford Univ, Cardiovasc Inst, Stanford, CA USA
[3] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA
[4] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA USA
[5] Kaiser Permanente San Francisco Med Ctr, Dept Cardiol, San Francisco, CA USA
[6] Div Res, San Francisco, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 84卷 / 13期
关键词：
cholesterol; disparities; performance measure; prevention;
D O I：
10.1016/j.jacc.2024.07.025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1272 / 1275
页数：4
相关论文
共 50 条
  • [1] New Insights in the Control of Low-Density Lipoprotein Cholesterol to Prevent Cardiovascular Disease
    Katzmann, Julius L.
    Laufs, Ulrich
    CURRENT CARDIOLOGY REPORTS, 2019, 21 (08)
  • [2] Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
    Willeit, Peter
    Yeang, Calvin
    Moriarty, Patrick M.
    Tschiderer, Lena
    Varvel, Stephen A.
    McConnell, Joseph P.
    Tsimikas, Sotirios
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (23):
  • [3] New Insights in the Control of Low-Density Lipoprotein Cholesterol to Prevent Cardiovascular Disease
    Julius L. Katzmann
    Ulrich Laufs
    Current Cardiology Reports, 2019, 21
  • [4] Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol
    Yeang, Calvin
    Karwatowska-Prokopczuk, Ewa
    Su, Fei
    Dinh, Brian
    Xia, Shuting
    Witztum, Joseph L.
    Tsimikas, Sotirios
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (11) : 1035 - 1046
  • [5] The Future of Low-Density Lipoprotein Cholesterol in an Era of Nonfasting Lipid Testing and Potent Low-Density Lipoprotein Lowering
    Farukhi, Zareen
    Mora, Samia
    CIRCULATION, 2018, 137 (01) : 20 - 23
  • [6] Statins, low-density lipoprotein cholesterol, and risk of cancer
    Alsheikh-Ali, Alawi A.
    Trikalinos, Thomas A.
    Kent, David M.
    Karas, Richard H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (14) : 1141 - 1147
  • [7] Future approaches to reducing low-density lipoprotein cholesterol
    Wierzbicki, Anthony S.
    FUTURE LIPIDOLOGY, 2006, 1 (04): : 463 - 476
  • [8] Perspectives on low-density lipoprotein cholesterol goal achievement
    Catapano, Alberico L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (02) : 431 - 447
  • [9] Low-Density Lipoprotein Cholesterol Targeting: A Continued Controversy
    Whayne, Thomas F., Jr.
    ANGIOLOGY, 2014, 65 (03) : 263 - 264
  • [10] Lipoprotein(a) Cholesterol Masquerading as Low-Density Lipoprotein Cholesterol Catch Me if You Can
    Pare, Guillaume
    Chong, Michael
    Mohammadi-Shemirani, Pedrum
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (11) : 1047 - 1049
12345